MICHELLE BLAKE — Lobbyist Profile | Poliscope

MICHELLE BLAKE

Filings

Clients

Firms

Years active

2023–2023

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
PHOENIX ZONES INITIATIVE	2	2023

Lobbying firms

Firm	Filings	Years
WIDERCHANGE LLC	2	2023

Bills explicitly cited in this lobbyist’s assigned issues (2)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1024

COVID–19 Supply Chain Resiliency Act of 2021

Client: PHOENIX ZONES INITIATIVE · Firm: WIDERCHANGE LLC

Open original LDA filing ↗

Cited source text

HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and topics related to the FDA Modernization Act of 2021. Brief conversations with staff members addressed past and current legislative efforts to replace animal testing with non-animal methods, anticipated public benefits of modernizing medical research to be human-centered, the need to extend research protections to nonhuman animals.

H.R. 1024

COVID–19 Supply Chain Resiliency Act of 2021

Client: PHOENIX ZONES INITIATIVE · Firm: WIDERCHANGE LLC

Open original LDA filing ↗

Original LDA source filings (2)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

PHOENIX ZONES INITIATIVE via WIDERCHANGE LLC

2023 · first_quarter · 1A

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

ANI

Animals

HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and topics related to the FDA Modernization Act of 2021. Brief conversations with staff members addressed past and current legislative efforts to replace animal testing with non-animal methods, anticipated public benefits of modernizing medical research to be human-centered, the need to extend research protections to nonhuman animals.

MED

Medical/Disease Research/Clinical Labs

HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and issues related to the FDA Modernization Act of 2021. Brief conversations with staff members discussed patient benefits of modernize medical testing.

Source: Senate LDA